News
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
1d
Zacks.com on MSNNVO Stock Up on FDA Nod for Wegovy in MASH: More Upside Ahead?
Novo Nordisk surges as Wegovy secures FDA approval for MASH, marking a breakthrough in liver care and expanding its blockbuster reach.
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those with previous adverse reactions.
GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both Novo Nordisk's GLP-1 drugs, Ozempic and Wegovy, at a cash price of $499 per month.
Tools like Claimable and Fight Health Insurance use AI to guide people through the insurance appeals process and generate ...
Longer-term studies will be needed to track whether per-patient costs might drop over time with continued use of the meds.
The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its ...
People enrolled in the military health care benefits program Tricare for Life no longer will be eligible for coverage of ...
GoodRx (GDRX) is joining in on the GLP-1 action with an announcement on Monday that it will begin selling both of Novo Nordisk's (NVO) GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at ...
6d
Zacks Investment Research on MSNNovo Nordisk Rises 6% So Far in August: How to Play the Stock
Novo Nordisk NVO faced a significant setback in July after sharply reducing its 2025 outlook for both sales and operating ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
FAIRMONT — CVS Caremark owes the State of West Virginia $1.4 million in civil penalties after the state’s insurance commissioner found it violated state code. The $1.4 million fine is based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results